At 48 weeks, the weight loss results were striking across all dose groups
Retatrutide: Weekly injection per standard escalation protocol BPC-157: 0.25 to 0.5 mg daily, subcutaneous TB-500 Loading (Weeks 1-4): 2.5 mg Monday and Thursday TB-500 Maintenance (Weeks 5+): 2 mg every 7 to 14 days Total Duration: 6 to 8 weeks with 4 weeks off before repeating The GLOW Protocol: Triple Healing Power The GLOW protocol extends the Wolverine Stack by adding GHK-Cu, creating a comprehensive regeneration stack that addresses healing, inflammation, and skin health simultaneously
It is a dual incretin agonist, engaging both GLP-1 and GIP receptors
doi: 10.1093/jn/133.5.1302 54 YooWZiebaJKFoegedingNJTorresTPSheltonCDShealyNGet al
Built-In Exit Strategy The goal is to reduce or stop GLP-1 medication once your body is metabolically healthy
Krause GC, Lima KG, Dias HB, et al